Company / Accounts Receivable
Surgery Partners, Inc. Accounts Receivable History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$579.1M
FY2024
5-year range
$382.2M / $579.1M
FY2020-FY2024
Trend
+16.7%
vs FY2023
Sector context
#41 of 138
Health Care
What the data says
At $579M, Surgery Partners, Inc.'s accounts receivable ranks #41 of 138 in the Health Care sector. Accounts Receivable has increased for 9 consecutive years, from $178M in FY2015 to $579M in FY2024.
Based on SEC 10-K filings.
$579M in FY2024 with a 5-year CAGR of +12.1%.
Improved from $456M to $579M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
#41 of 138 in Health CareTop 30% of 138This company $579.1M Sector average $1.3B
▼
-56.2% below sector average
Key checks
Key Insights
- Surgery Partners, Inc.'s accounts receivable has grown for 9 consecutive years.
- 5-year CAGR of +12.1%, indicating consistent growth.
- In FY2024, accounts receivable increased 16.7% year-over-year.
- Ranks #41 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.31 (distress zone, below 1.8 threshold)
- Negative profit margin: -14.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $579.1M | +16.7% |
| FY2023 | $496.4M | +8.8% |
| FY2022 | $456.3M | +6.1% |
| FY2021 | $430.2M | +12.6% |
| FY2020 | $382.2M | +16.9% |
| FY2019 | $326.9M | +6.3% |
| FY2018 | $307.6M | +6.8% |
| FY2017 | $288.0M | +30.6% |
| FY2016 | $220.6M | +24.1% |
| FY2015 | $177.8M | +22.6% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026